NDC 0378-9072-16 - Rivastigmine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-9072
- Requested NDC
- 0378-9072-16
- Package NDCs from labels
- 0378-9072-16, 0378-9072-93
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2024-09-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rivastigmine - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2024-09-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-9072-16 | Rivastigmine | 24 h in 1 PATCH | PATCH | 24 | 10 | |
| 0378-9072-16 | Rivastigmine | 1 in 1 POUCH | PATCH | 1 | 10 | |
| 0378-9072-93 | Rivastigmine | 30 in 1 CARTON | PATCH | 30 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-9072-16 | EA - Each | 0378-9072 | abb14a85-0014-4176-935c-4e32e0f78262 | 1 | 2019-10-07 |
| 0378-9072-93 | EA - Each | 0378-9072 | 666f3027-9917-4851-a6ae-0da8e40b47a5 | 1 | 2018-07-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | a68d70c9-19f2-47db-bf78-4da04a87a702 | 2025-03-20 | Warnings, Adverse reactions | 725023 PKI06M3IW0 |
| CVS Health Stool Softener Plus stimulant laxative Softgel | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy, Inc | 2881d83d-9929-677a-e063-6394a90a0424 | 2025-03-19 | Warnings | F05Q2T2JA0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Bryant Ranch Prepack | 6cc286d9-c5d4-4505-83bb-9015e3077851 | 2025-03-19 | Warnings, Adverse reactions | 1308569 PKI06M3IW0 |
| RID Poison Ivy Rash Relief | CALAMINE AND ZINC OXIDE | Oystershell Consumer Health Inc. | 36c3af9a-2646-4427-e063-6394a90a2c5e | 2025-03-13 | Warnings | 1K09F3G675 |
| Se-Natal 19 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM | Seton Pharmaceuticals | 635104e6-6a53-4684-ac9a-7ac31b33083d | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| Stool Softener and Stimulant Laxative | DOCUSATE SODIUM, SENNOSIDES | H-E-B | c19280c2-f968-b582-e053-2995a90a9bd3 | 2025-02-14 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER-STIMULANT LAXATIVE | STOOL SOFTENER-STIMULANT LAXATIVE | Kroger Company | a22c9f95-e3a9-bfd3-e053-2995a90a3c66 | 2025-02-13 | Warnings | F05Q2T2JA0 |
| Calamine | FERRIC OXIDE RED | Preferred Pharmaceuticals Inc. | 326f3d80-c1bf-4cf0-a662-58e02ed7ee67 | 2025-02-12 | Warnings, Adverse reactions | 1K09F3G675 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | KROGER | a187045c-c9d6-592a-e053-2995a90adb83 | 2025-02-10 | Warnings | F05Q2T2JA0 |
| SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES | TIME CAP LABORATORIES, INC | dc491692-8d3a-4ccd-a17d-4c630f122595 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM | TIME CAP LABORATORIES, INC | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Asclemed USA, Inc. | 2db546de-20dc-4697-aff2-12471f073b1d | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PAI Holdings, LLC dba PAI Pharma | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 2025-02-06 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM 50MG SOFTGEL (RED) | DOCUSATE SODIUM | CVS Pharmacy | 273e5b52-1cf9-2525-e063-6394a90a8b4f | 2025-02-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | NuCare Pharmaceuticals, Inc. | 2c65319f-6cf5-aa90-e063-6394a90ad662 | 2025-01-23 | Warnings | F05Q2T2JA0 |
| Prunus Iron | PRUNUS IRON | Uriel Pharmacy Inc. | 091be588-b62e-4919-8e9e-3edb9792d319 | 2025-01-22 | Warnings | 1K09F3G675 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Rivastigmine Transdermal System | RIVASTIGMINE | Breckenridge Pharmaceutical, Inc. | b201fe68-b5e5-4a6f-8cf1-069543f03e76 | 2025-01-15 | Warnings, Adverse reactions | 725021 1308569 725023 PKI06M3IW0 |
| Stool Softener Laxative | DOCUSATE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 4d678da0-9ada-4d00-9db9-33b45c776107 | 2025-01-15 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Ulai Health LLC | c0e27b02-8ef2-4239-8f8c-790f7d978dc0 | 2025-01-12 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.